The expanded indication extends Lilly's JAK inhibitor to adolescents aged 12 years and older with severe alopecia areata.

The European Commission has authorised Icotyde for adults and adolescents with moderate-to-severe plaque psoriasis who are candidates for systemic therapy.

The FDA has expanded the approved use of Ameluz with red-light photodynamic therapy to include treatment of superficial basal cell carcinoma in adults.

Average annual compensation for US dermatologists reached $497,509 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in dermatology.

The approval provides clinicians with a dedicated injectable treatment for moderate to severe infraorbital hollowing in adults aged 22 years and older, expanding aesthetic treatment options for the under-eye region.

The agreement adds a late-stage oral therapy for rare genetic photodermatoses to LEO Pharma's dermatology pipeline while expanding its focus on rare skin diseases.

New physician payment data show dermatologists generated higher median gross billings in British Columbia than in Manitoba.

Dermatology earnings flatten: positioning now defines outcomes, not progression